22 February 2019 - The Australian Government will invest $10 million to expand access to a medicine for attention deficit hyperactivity disorder.
The Liberal National Government will invest $10 million to expand access to a medicine for attention deficit hyperactivity disorder (ADHD).
Intuniv (guanfacine) for the treatment of ADHD will be made available as an add-on therapy to other ADHD medicines on the Pharmaceutical Benefits Scheme from March 1 this year.